Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) – Kentucky, USA, 2020
Background: As vaccine supply and access remain limited in many parts of the world, understanding the duration of protection from reinfection after natural infection is important. Methods: Distinct individuals testing positive and negative for SARS-CoV-2 between March 6, 2020, and August 31, 2020, i...
Guardado en:
Autores principales: | Kevin B. Spicer, Connor Glick, Alyson M. Cavanaugh, Douglas Thoroughman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d7bbdcf9f7b74630b1808951795cc78d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Symptomatic severe acute respiratory syndrome coronavirus 2 reinfection in a lupus patient treated with hydroxychloroquine: a case report
por: Astrid Muyldermans, et al.
Publicado: (2021) -
COVID-19 reinfection: the role of natural immunity, vaccines, and variants
por: Bao Y. Sciscent, et al.
Publicado: (2021) -
Repeat positive SARS-CoV-2 RNA testing in nursing home residents during the initial 9 months of the COVID-19 pandemic: an observational retrospective analysis
por: Jillian N. Armstrong, M.S., et al.
Publicado: (2021) -
Risk factors associated with prolonged viral clearance in patients with a refractory course of COVID-19: a retrospective study
por: Weitao Zhuang, et al.
Publicado: (2021) -
Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
por: Ramesh Kandimalla, et al.
Publicado: (2021)